Zdzisława Kornacewicz-Jach Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

9/2017	Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
2/2011	AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
9/2008	Diagnostic and prognostic value of rapid pacing stress echocardiography for the detection of coronary artery disease: influence of pacing mode and concomitant antiischemic therapy (final results of multicenter study Pol-RAPSE).
3/2007	Usefulness of early dobutamine stress echocardiography for the assessment of risk of restenosis after percutaneous coronary interventions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zdzisława Kornacewicz-Jach Research Topics

Disease

5	Heart Failure 11/2017 - 04/2007
4	Myocardial Infarction 07/2019 - 07/2003
4	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 09/2017 - 03/2007
3	ST Elevation Myocardial Infarction 01/2020 - 06/2006
3	Cardiotoxicity 11/2017 - 10/2014
3	Cardiac Arrhythmias (Arrythmia) 02/2016 - 07/2006
2	Atrial Fibrillation 09/2017 - 01/2009
2	Ischemic Stroke 09/2017 - 03/2004
2	Stroke (Strokes) 09/2017 - 05/2008
2	Inflammation (Inflammations) 02/2016 - 01/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2019
1	Neoplasms (Cancer) 11/2017
1	Hypertension (High Blood Pressure) 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Atherosclerosis 03/2017
1	Ventricular Tachycardia 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016
1	Ventricular Fibrillation 02/2016
1	Pulmonary Hypertension 01/2015
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2014
1	Obesity 02/2011
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2009
1	Sinus Tachycardia 01/2009
1	Carotid Stenosis (Carotid Artery Stenosis) 05/2008
1	Thrombosis (Thrombus) 05/2008
1	Necrosis 01/2008
1	Acute Coronary Syndrome 01/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2007
1	Hypertrophy 06/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2007
1	Coronary Restenosis 03/2007
1	Hypopituitarism (Sheehan's Syndrome) 04/2006
1	Coronary Disease (Coronary Heart Disease) 06/2005
1	Mitral Valve Prolapse 03/2004
1	Aneurysm (Aneurysms) 03/2004

Drug/Important Bio-Agent (IBA)

3	AnthracyclinesIBA 01/2018 - 10/2014
2	pro-brain natriuretic peptide (1-76)IBA 09/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 01/2008
2	C-Reactive ProteinIBA 02/2016 - 01/2008
1	Angiopoietin-1IBA 07/2019
1	Platelet-Derived Growth FactorIBA 07/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2019
1	Epirubicin (Ellence)FDA LinkGeneric 11/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017
1	Cytotoxins (Cytolysins)IBA 11/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2017
1	Plasminogen Activator Inhibitor 1IBA 09/2017
1	FibrinIBA 09/2017
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 09/2017
1	CreatinineIBA 09/2017
1	Clopidogrel (Plavix)FDA Link 09/2017
1	Cytochrome P-450 CYP2C19IBA 09/2017
1	LipidsIBA 03/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Troponin IIBA 01/2016
1	TroponinIBA 01/2016
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2015
1	Phosphodiesterase InhibitorsIBA 01/2015
1	Bosentan (Tracleer)FDA Link 01/2015
1	Sildenafil Citrate (Viagra)FDA Link 01/2015
1	Iloprost (Ventavis)FDA Link 01/2015
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 10/2014
1	Nonsense Codon (Nonsense Mutation)IBA 02/2011
1	Adenosine Monophosphate (AMP)IBA 02/2011
1	Heparin (Liquaemin)FDA LinkGeneric 05/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2008
1	Atorvastatin (Lipitor)FDA Link 01/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2008
1	Indicators and Reagents (Reagents)IBA 01/2008
1	Dichlorodiphenyldichloroethane (DDD)IBA 06/2007
1	Dobutamine FDA LinkGeneric 03/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2006
1	Type 1 Angiotensin ReceptorIBA 02/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2006
1	HDL CholesterolIBA 06/2005

Therapy/Procedure

11	Therapeutics 01/2020 - 03/2004
5	Drug Therapy (Chemotherapy) 01/2018 - 10/2014
4	Percutaneous Coronary Intervention 09/2017 - 06/2006
2	Defibrillators (Defibrillator) 10/2009 - 01/2009
2	Stents 05/2008 - 07/2003
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2019
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2009
1	Embolectomy 05/2008
1	Cardiac Resynchronization Therapy 04/2007
1	Patient Readmission 07/2006
1	Thrombolytic Therapy 06/2006
1	Hormonal Contraception 03/2004